Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy Against Tuberculosis

mBio - United States
doi 10.1128/mbio.02627-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

The Use of Transcriptomics to Predict Drug Efficacy and Treatment Outcome in Tuberculosis

2016English

Quantifying Drug Combination Synergy Along Potency and Efficacy Axes

Cell Systems
Forensic MedicinePathologyCell BiologyHistology
2019English

SynToxProfiler: An Interactive Analysis of Drug Combination Synergy, Toxicity and Efficacy

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2020English

Thiazomycin, Nocathiacin and Analogs Show Strong Activity Against Clinical Strains of Drug-Resistant Mycobacterium Tuberculosis

Journal of Antibiotics
Drug DiscoveryPharmacology
2017English

Efficacy of Four Drug Regimen vs. Three Drug Regimen in Patients of Tuberculous Lymphadenitis, Registered at S.N Medical College, Agra

Journal of Medical Science And clinical Research
2018English

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Transcriptomic Signatures Decode Th17 Cell Pathogenicity

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2016English

Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin Against Mycobacterium Tuberculosis: Evaluation of in Vitro and Pharmacodynamic Indices That Best Predict in Vivo Efficacy

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Clinical Proteomics and Bioinformatics: Exploring Drug Resistant Tuberculosis

Journal of Proteomics & Bioinformatics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy